Terms search
1
Arthritis & Rheumatism - Abstract Supplement, 2010 Annual Scientific Meeting – Volume 62, #10 of Journal of the American College of Rheumatology ACR – Wiley-Blackwell ACR
ACR; (2010)
2
Communications affichées
3
Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5
Jaclyn K. Anderson; Lani Zimmerman; Liron Caplan; Kaleb Michaud
4
Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?
Ole Rintek Madsen
5
Communications affichées
6
Comparative study of indices of activity evaluation in rheumatoid arthritis
W. Hamdi; O. Néji; M.M. Ghannouchi; D. Kaffel; M.M. Kchir
7
¿Es la puntuación DAS28 el método más adecuado para estimar la actividad de la artritis reumatoide? Consideracionens clinimétricas y escenarios de simulación
Miguel Ángel Belmonte Serrano
8
Predictors of change in bodily pain in early rheumatoid arthritis: An inception cohort study
Daniel F. McWilliams; Weiya Zhang; Josephine S. Mansell; Patrick D. W. Kiely; Adam Young; David A. Walsh
9
Abstracts
10
Abstracts der DGRh
11
Comparison of composite disease activity indices for rheumatoid arthritis
Toshihiro Matsui; Yoshiaki Kuga; Jinju Nishino; Atsushi Kaneko; Yoshito Eto; Shigeto Tohma
12
39. Kongress der Deutschen Gesellschaft für Rheumatologie
13
Brief Report: To squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis
P. H. de Jong; A. E. Weel; Y. A. de Man; A. M. Huisman; A. H. Gerards; M. V. van Krugten; J. J. Luime; J. M. Hazes
14
Communications affichées
15
Serum adenosine deaminase may predict disease activity in rheumatoid arthritis
Zamani; Batool; Jamali; Raika; Jamali; Arsia
16
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints
Daniel Aletaha; Josef S. Smolen
17
Atlas of rheumatoid arthritis
Emery; Paul
18
Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis
Yaël A. de Man; Johanna M. W. Hazes; Fleur E. van de Geijn; Catharina Krommenhoek; Radboud J. E. M. Dolhain
19
The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis
Behzad HEIDARI; Parham HEIDARI; Muhammad Ebrahim TAYEBI
20
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
Curtis; Jeffrey R.; van der Helm-van Mil; Annette H.; Knevel; Rachel; Huizinga; Tom W.; Haney; Douglas J.; Shen; Yijing; Ramanujan; Saroja; Cavet; Guy; Centola; Michael; Hesterberg; Lyndal K.; Chernof
21
Abstracts
22
Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study
Norihiro Nishimoto; Nobuhiro Takagi
23
DAS28 and Rheumatoid Arthritis: The Need for Standardization
Duncan Porter; Kate Gadsby; Paul Thompson; Jo White; Catherine McClinton; Sue Oliver
24
Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
Cécile Gaujoux-Viala; Gaël Mouterde; Athan Baillet; Pascal Claudepierre; Bruno Fautrel; Xavier Le Loët; Jean-Francis Maillefert
25
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants
Josef S. Smolen; Daniel Aletaha
26
Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record–based disease activity calculator
Deborah S. Collier; Richard W. Grant; Greg Estey; Dominic Surrao; Henry C. Chueh; Jonathan Kay
27
RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol
Theodore Pincus; Victoria Furer; Edward Keystone; Yusuf Yazici; Martin J. Bergman; Kristel Luijtens
28
Evaluation of disease activity indices in Korean patients with rheumatoid arthritis
So-Yeon Park; Hyeseon Lee; Soo-Kyung Cho; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae
29
Reliability of patient self-evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessments
Peter P. Cheung; Adeline Ruyssen-Witrand; Laure Gossec; Simon Paternotte; Catherine Le Bourlout; Maryse Mazieres; Maxime Dougados
30
RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): Agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds
Theodore Pincus; Christopher J. Swearingen; Martin J. Bergman; C. Lee Colglazier; Alan T. Kaell; Arthur M. Kunath; Evan L. Siegel; Yusuf Yazici
31
Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience
Singh; H.; Gupta; V.; Ray; S.; Kumar; H.; Talapatra; P.; Kaur; M.; Kumar; S.; Arya; S.; Mathur; R.; Ghangas; N
32
Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds
Nikiphorou; Elena; Norton; Sam; Young; Adam; Carpenter; Lewis; Dixey; Josh; Walsh; David Andrew; Kiely; Patrick
33
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti–tumor necrosis factor α therapy
Jing Cui; Saedis Saevarsdottir; Brian Thomson; Leonid Padyukov; Annette H. M. van der Helm-Van Mil; Joanne Nititham; Laura B. Hughes; Niek de Vries; Soumya Raychaudhuri; Lars Alfredsson; Johan Askling
34
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models
Jenko; Barbara; Tomšič; Matija; Jekić; Biljana; Milić; Vera; Dolžan; Vita; Praprotnik; Sonja
35
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
Gerd R. Burmester; Gianfranco Ferraccioli; René-Marc Flipo; Indalecio Monteagudo-Sáez; Kristina Unnebrink; Sonja Kary; Hartmut Kupper
36
Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)
Jaap Fransen; Gerold Stucki; Piet L. C. M. van Riel
37
Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
Leffers; H. C.; Ostergaard; M.; Glintborg; B.; Krogh; N. S.; Foged; H.; Tarp; U.; Lorenzen; T.; Hansen; A.; Hansen; M. S.; Jacobsen; M. S.; Dreyer; L.; Hetland; M. L
38
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
Daniel Aletaha; Michael M. Ward; Klaus P. Machold; Valerie P. K. Nell; Tanja Stamm; Josef S. Smolen
39
Predictors for remission in rheumatoid arthritis patients: A systematic review
Wanruchada Katchamart; Sindhu Johnson; Hsing-Ju Lucy Lin; Veerapong Phumethum; Carine Salliot; Claire Bombardier
40
Comparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern India
Anirban Ghosh; Biswadip Ghosh; Shantashil Pain; Arindam Pande; Sandip Saha; Arnab Banerjee; Amit Baran Biswas
41
The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients
Burkhard F. Leeb; Ingrid Andel; Judith Sautner; Christian Fassl; Thomas Nothnagl; Bernhard Rintelen
42
2.3. Rheumatoid arthritis - anti-TNFα therapy
43
Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study
Yoshitaka Morita; Yumi Sasae; Takeo Sakuta; Minoru Satoh; Tamaki Sasaki; Naoki Kashihara
44
Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients?
M. Levitus; A. Pelliccia; R. J. van de Stadt; A. E. Voskuyl; A. A. Bouman
45
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study
Marloes Vermeer; Hillechiena H. Kuper; Monique Hoekstra; Cees J. Haagsma; Marcel D. Posthumus; Herman L. M. Brus; Piet L. C. M. van Riel; Mart A. F. J. van de Laar
46
Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine
Burkhard F. Leeb; Ingrid Andel; Judith Sautner; Mirela Bogdan; Adil Maktari; Thomas Nothnagl; Bernhard Rintelen
47
Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level
Keiko Funahashi; Satoru Koyano; Takako Miura; Takafumi Hagiwara; Kosuke Okuda; Tsukasa Matsubara
48
Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis
Jennifer L. Barton; John Imboden; Jonathan Graf; David Glidden; Edward H. Yelin; Dean Schillinger
